Menu
Back to Journals » ClinicoEconomics and Outcomes Research » Volume 9
Corrigendum
Potential resource and cost saving analysis of subcutaneous versus intravenous administration for rituximab in non-Hodgkin’s lymphoma and for trastuzumab in breast cancer in 17 Italian hospitals based on a systematic survey [Corrigendum]
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 8,109 | Dovepress* | 7,866+ | 1,687 | 9,553 | |
| PubMed Central* | 243 | 125 | 368 | ||
| Totals | 8,109 | 1,812 | 9,921 | ||
| *Since 17 January 2017 | |||||
View citations on PubMed Central and Google Scholar